Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: Risk or opportunity?

Journal of the American Academy of Dermatology

Volumn 63, Issue 2, 2010, Pages 342-343

  Di Lernia, Vito ^a   Albertini, Giuseppe ^a  

^a Arcispedale S Maria Nuova ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; BETA INTERFERON; CYCLOSPORIN A; ETANERCEPT; ETRETIN; INTERFERON; PEGINTERFERON; PSORALEN; RIBAVIRIN; TUMOR NECROSIS FACTOR INHIBITOR; CYCLOSPORIN; DERMATOLOGICAL AGENT;

AMINOTRANSFERASE BLOOD LEVEL; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; DRUG DOSE REDUCTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; MONOTHERAPY; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; TREATMENT CONTRAINDICATION; ULTRAVIOLET A RADIATION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; NOTE; RISK FACTOR;

CYCLOSPORINE; DERMATOLOGIC AGENTS; HEPATITIS C, CHRONIC; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSORIASIS; RISK FACTORS;

EID: 77955283318     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.11.593     Document Type: Letter

References (10)

1. A.J. Frankel, A.S. Van Voorhees, S. Hsu, N.J. Koran, M.G. Lebowl, and B.F. Bebo Jr. et al. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation J Am Acad Dermatol 61 2009 1044 1055
2. H. Akiyama, H. Yoshinaga, T. Tanaka, K. Hiruma, S. Tanikawa, and H. Sakamaki et al. Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients. Bone Marrow Transplantation Team Bone Marrow Transplant 20 1997 993 995
3. K. Watashi, M. Hijikata, M. Hosaka, M. Yamaji, and K. Shimotohno Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes Hepatology 38 2003 1282 1288
4. K. Inoue, K. Sekiyama, M. Yamada, T. Watanabe, H. Yasuda, and M. Yoshiba Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial J Gastroenterol 38 2003 567 572
5. K. Inoue, T. Watanabe, M. Yamada, H. Yoshikumi, O. Ogawa, and M. Yoshiba Efficacy of interferon beta combined with cyclosporine induction and intensified therapy for retreatment of chronic hepatitis C Transplant Proc 41 2009 246 249
6. K. Nanmoku, R. Imaizumi, T. Tojimbara, I. Nakajima, S. Fuchinoue, and N. Sakamoto et al. Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy Transplant Proc 40 2008 2382 2385
7. M. Nakagawa, N. Sakamoto, Y. Tanabe, T. Koyama, Y. Itsui, and Y. Takeda Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins Gastroenterology 129 2005 1031 1041 (Pubitemid 41242693)
8. H. Miura, Y. Itoh, Y. Matsumoto, M. Tani, N. Tanabe, and M. Isonokami Long-term administration of cyclosporin A to HCV-antibody-positive patients with dermatologic diseases Int J Dermatol 38 1999 310 314 (Pubitemid 29189641)
9. M. Galeazzi, F. Bellisai, C. Giannitti, S. Manganelli, G. Morozzi, and S.D. Sebastiani Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection Ann N Y Acad Sci 1110 2007 544 549 (Pubitemid 350043044)
10. R. Manna, E. Verrecchia, C. Fonnesu, M. Giovinale, G. De Socio, and V. Curigliano et al. Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection? Eur Rev Med Pharmacol Sci 13 suppl 1 2009 63 69